ArticleThe American journal of case reports2017

Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Single Center Experience of Two Cases.

Armando Bedoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.